Author： Pickett Andy
Publisher： Adis International
ISSN： 1174-5886
Source： Drugs in R&D, Vol.11, Iss.1, 2011-03, pp. : 97-98
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Botulinum toxin type A for the treatment of migraine
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. :
Access to resources
Recommend
Botulinum Toxin Type A for Facial Rejuvenation
Dermatologic Surgery, Vol. 24, Iss. 11, 1998-11 ,pp. :
Analysis of Botulinum Toxin Products and Litigation in the United States
By Korman John B. Jalian H. Ray Avram Mathew M.
Dermatologic Surgery, Vol. 39, Iss. 11, 2013-11 ,pp. :
Dermatologic Surgery, Vol. 24, Iss. 11, 1998-11 ,pp. :
US FDA reviewing safety of botulinum toxin type A and B
Reactions Weekly, Vol. 1, Iss. 1189, 2008-01 ,pp. :